{"nct_id":"NCT03980483","title":"Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate","status":"COMPLETED","status_verified_date":"2024-03","start_date":"2019-05-16","start_date_type":"ACTUAL","primary_completion_date":"2021-09-15","primary_completion_date_type":"ACTUAL","completion_date":"2022-08-16","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}